The Willamette Angels Conference, an investment conference that connects startups with angel and venture investors, is scheduled for 11:30 a.m. to 5 p.m. Thursday at the Whiteside Theatre, 361 S.W. Madison Ave. in Corvallis.
Five finalists are vying to become the conference winner, though other new companies featured may secure investment deals, as well.
The 2017 WAC finalists were selected from a pool of 44 applicants after an exhaustive process:
• Costanoan Biotechnologies of Portland designs, develops and manufactures membranes for the purification of high value therapeutic proteins from complex solutions.
• Diatomix of Beaverton has developed a bioengineered photocatalytic technology that actively and continuously improves indoor air quality.
• Hemex Health of Portland provides new diagnostics for malaria and sickle cell disease where there’s no viable test today.
• Heritage Laboratories of Eugene is a luxury skincare supplement brand targeting Asian American women.
• OpConnect, Inc. of Portland operates a platform-as-a-service that manages electric car chargers made by a number of manufacturers to help charger owners maximize revenue.
Throughout its eight years, the conference has invested more than $3 million in startup businesses, according to a news release.
Last year, the Willamette Angels invested $1.2 million in startup businesses. That included $300,000 to Willamette Angels Conference co-winner Code3Simulator, based in Corvallis, and $100,000 to conference co-winner Agility Robotics, based in Albany.
The Willamette Angels Conference is produced in partnership by the Corvallis Chamber of Commerce and Oregon RAIN (Regional Accelerator & Innovation Network) and supported by the Eugene Area Chamber of Commerce and the Corvallis-Benton Economic Development Office.
Tickets for the conference are $110 or $85 for chamber members and RAIN alumni. For more information, go to www.willametteconference.com.